Press Release | New book series aims to provide frontier reviews on anti-infective agents

 

post news.jpg

 

Frontiers in Anti-Infective Agents is a book series that focuses on antibiotics and vaccines, both current and new.

The series is essential reading for general readers, healthcare professionals, researchers and academicians actively involved in research on infectious diseases and anti-infective therapeutic drugs.

The first volume is a comprehensive documentation on major infectious diseases from tropical countries which pose a serious threat to global healthcare programs. These include diseases such as tuberculosis, AIDS, leishmaniasis (kala-azar), elephantiasis, malaria, leprosy, various fungal disorders and emergent viral diseases. Due to the widespread use of antibiotics, there is an emergence of drug resistant pathogens in many regions. Hence, there is a need to search for novel, cost-effective bioactive compounds that demonstrate high efficacy and low toxicity in human cells from unexplored ecosystems to combat emerging drug resistant pathogens. Chapters written for this volume focus on the pathogenesis and etiology of each of the mentioned diseases, updated WHO reports wherever applicable, conventional drugs and their pharmacokinetics as well as new approaches to develop anti-infective agents.

The authors also present a detailed report on multi-drug resistant pathogens (‘superbugs’) and new measures being taken up to eradicate them. Information about new antimicrobials (bioactive peptides and silk protein sericin) and the approaches taken by scientists and healthcare professionals for successful targeting of these molecules for human medicine. For more information, please visit: https://benthambooks.com/book/9789811432736/https://benthambooks.com/book/9789811432736/

About The Editors:

Dr. K. Tamreihao completed his PhD and Master of Science from the Department of Biochemistry, Manipur University, India. He is working as PDF in a project sponsored by Department of Biotechnology, Government of India. His research interest lies in the area of plant growth promotion by actinobacteria and feather degradation by keratinolytic actinobacteria and the biofertilizing potential of degraded feathers.

Dr Saikat Mukherjee completed his M.Sc (Biotechnology) from Calcutta University and PhD from CSIR- Indian Institute of Chemical Biology, Kolkata. He has participated in postdoctoral research programs in University of Geneva, Switzerland and Manipur University, India. His research expertise is in mitochondrial bioenergetics and purification of protein complexes from protozoal, human, bacterial and algal systems.

Prof. Debananda S. Ningthoujam earned his Masters of Science (Life Sciences) from Jawaharlal Nehru University, New Delhi and PhD (Environmental Biotechnology) from NEERI, Nagpur. He is currently working as a Professor of Biochemistry at the university of Manipur. Prof. Ningthoujam is a life member of several scientific society including AMI, BRSI, SBC, ASM and ISCA. He is actively researching actinomycete biology and biotechnology and has several completed and ongoing projects to his credit. Six new actinomycete species have been reported from his lab. Prof. Ningthoujam has over 25 years of teaching experience and five research scholars have earned their PhDs under his mentorship. He has also supervised several PDF candidates.

READ FULL PRESS RELEASE TO FIND OUT MORE: https://www.eurekalert.org/pub_releases/2019-12/bsp-nbs122319.php

SMi EVENT – Superbugs and Superdrugs USA 2017

Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017.

200X200-Superbugs

Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates. As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.

For more information visit the website at http://www.superbugs-usa.com/bentham or contact the team on email: events@smi-online.co.uk or call +44 (0)20 7827 6000

Journal: Anti-Infective Agents 

EBook: Frontiers in Anti-Infective Drug Discovery

SMI EVENT – Superbugs & Superdrugs USA 14th November to 15th November 2016, Iselin, USA!

Drawing on our 18 years’ of experience in the sector, SMi proudly presents the inaugural Superbugs & Superdrugs USA Conference & Exhibition in New Jersey, November!

The recent rare superbug outbreak in Wisconsin* which  is now blamed for the deaths of 18 people has rendered the attention amongst superbug and superdrug professionals again.  Despite advanced healthcare and antibiotics, more than 100,00 people die from hospital-acquired infections per year, which equates to 4%  of patient populations in the US. Scientists now have to gear to combat on resistance to antimicrobials, implant-related resistant infections and mutation of bacterial. A recent study** stated that bacterial wall ‘gates’ could lead to new anti-superbug drugs. As such, SMi is excited to extend our premier Superbugs & Superdrugs conference to the US this November, providing a timely platform for both pharmaceutical and healthcare experts to share their research updates and insights in this subject  – driving the rebuild of a global defensive wall of bacteria!

Registration is now live for this unmissable event. Visit http://www.superbugs-usa.com/bentham for more information.

SMI Event!

Superbugs & Superdrugs: 

200X200

25TH MARCH – 26TH MARCH 2015

Holiday Inn Regents Park Hotel, London UK

About the Event:

Superbugs and Superdrugs 2015 takes a holistic look at the issues and aims to equip delegates to take on the challenges of conserving the effectiveness of existing antibacterial drugs, developing new ones and tackling biosecuiry and Ebola threats. Bringing in voices from pharma, academia and government, this conference is the ideal meeting place to share the latest updates, case studies and strategies to seize the opportunities ahead and usher in the next generation of superdrugs. Join us as we ask the questions: How can new antibiotics be made available at affordable prices around the world? How has BARDA formed partnerships for the development of antibacterial therapies? What are the latest therapeutic developments to meet the global challenge? This really is a unique event not be missed. Download the brochure today and secure your place at http://www.smi-online.co.uk/goto/2015superdrugssuperbugs20.asp. Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email fbegum@smi-online.co.uk

For details, visit: http://www.smi-online.co.uk/goto/2015superdrugssuperbugs20.asp

%d bloggers like this: